t.tulloch
TL2 · Antalya
Contributes reviews on supplier material. Based in Antalya.
Joined 12 April 2025 · last posted 6h
89 posts, newest first. Showing up to 150.
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #47 · Clinical › Bloodwork · 28 Jul 2026 · 3 likes On egfr fluctuation: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply…
-
Tracking a shortage from primary sources rather than rumour Replied, post #97 · Access › Shortages · 11 Jul 2026 · 29 likes Manufacturer allocation decisions during a shortage are commercial and are rarely explained, which is frustrating and is not evidence of anything. If anyone can point…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #20 · Practice › Interactions · 7 Jul 2026 · 0 likes The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #23 · Evidence › Journal club · 4 Jul 2026 · 24 likes Post #20 is the version of this I will quote in future. One addition. The figures usually contain the finding and the text usually contains the interpretation.…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #53 · Compounds › Repair & healing peptides · 4 Jul 2026 · 7 likes I read post #50 twice before replying, because I had assumed the opposite. Where I have landed on absence of controlled human data, having got it wrong once in public:…
-
Prescription portability between countries Replied, post #80 · Access › International · 28 Jun 2026 · 4 likes Post #76 and I disagree about the size of the effect, not about the direction. If someone has run prescription portability between countries properly I would rather…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #34 · Outcomes › Body composition · 28 Jun 2026 · 0 likes Ultrasound and skinfolds is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #86 · Safety › Contraindications · 25 Jun 2026 · 18 likes Helpful, and short, which on this subject is harder than long.
-
Reading a trial's population section before its results Replied, post #98 · Evidence › Trials · 7 Jun 2026 · 26 likes The first question about any trial is what it set out to estimate, not what it found. Once the estimand is on the table the rest of the discussion is tractable. I…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #35 · Evidence › Journal club · 5 Jun 2026 · 15 likes STEP 1 came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #19 · Pharmacology › Pharmacokinetics · 31 May 2026 · 21 likes Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why the cytochrome interaction questions that dominate small-molecule…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #105 · Compounds › Tirzepatide · 30 May 2026 · 8 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
The anatomy of a question that gets answered within an hour Replied, post #50 · Start Here › How to Ask · 19 May 2026 · 19 likes Adding the measurement that post #49 says would settle it. When you quote a figure from somewhere else, say where from. Not as a formality — the answer frequently…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #103 · Practice › Reconstitution · 29 Apr 2026 · 0 likes What I can speak to on reconstitution volumes is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Follow-up: Lyophilisation and why the cake looks the way it does Replied, post #13 · Pharmacology › Formulation chemistry · 11 Apr 2026 · 6 likes Benzyl alcohol as a preservative is also a solubiliser for some peptides, which is an incidental property that occasionally matters.
-
Follow-up: State-level differences that actually matter Replied, post #92 · Regional › North America · 8 Apr 2026 · 27 likes Answering the question post #89 raises rather than the one it answers. State-level differences: I would want to see the raw numbers rather than the summary before…
-
Journal club: is percentage weight change the right endpoint? Replied, post #40 · Evidence › Journal club · 5 Apr 2026 · 3 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Preprint servers and what screening they do Replied, post #102 · Evidence › Preprints · 25 Mar 2026 · 0 likes Before the thread moves on from preprint servers — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #57 · Practice › Interactions · 20 Mar 2026 · 15 likes Where I part company with post #53, and it is a narrow parting. A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #70 · Clinical › Special populations · 12 Mar 2026 · 0 likes Post #68 describes the usual case. This is about the unusual one. Posting my pregnancy and pregnancy planning numbers with the method attached so they can be discounted…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #129 · Practice › Interactions · 10 Mar 2026 · 0 likes Where I part company with post #127, and it is a narrow parting. A request rather than an answer: could whoever has the primary source for Warfarin and altered intake…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #3 · Evidence › Journal club · 5 Mar 2026 · 9 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. The failure mode on SURMOUNT-4 and continuation versus withdrawal is boring…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #2 · Evidence › Journal club · 28 Feb 2026 · 28 likes An hour is enough for one paper read properly and not enough for two read partly. The temptation is always to add the second. The short answer was in the first line;…
-
Adolescents: a distinct evidence base — one year on Replied, post #69 · Clinical › Special populations · 27 Feb 2026 · 18 likes Adolescents is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which one…
-
MHRA statements, read directly Replied, post #93 · Regional › UK & Ireland · 20 Feb 2026 · 5 likes A referral pathway that worked eighteen months ago may not exist now. The archive keeps these posts and they are read as current.
-
Reading an interaction checker output critically Replied, post #114 · Practice › Interactions · 8 Feb 2026 · 0 likes Oral medications with a narrow therapeutic index are the ones where that matters most. The interaction is about rate and timing rather than about the total absorbed, in…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #15 · Practice › Administration · 31 Jan 2026 · 5 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #28 · Pharmacology › Pharmacokinetics · 30 Jan 2026 · 5 likes Post #24 and I disagree about the size of the effect, not about the direction. One caution on Washout: everything above assumes the underlying documentation is what it…
-
Cost per delivered dose, which is the number that matters Replied, post #42 · Access › Pricing · 25 Jan 2026 · 0 likes Cost per milligram is the only comparison that survives format differences, and even then it needs care.
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #11 · Practice › Side effects · 13 Jan 2026 · 2 likes Post #10 answers the question as asked. The question underneath it is different. Counterpoint on muscle cramps, offered without confidence: the same observation is…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #52 · Compounds › Semaglutide · 5 Jan 2026 · 26 likes The 165 to 184 hour half-life range gets quoted as a fixed number. It is a range across a studied population, and individual clearance varies enough that a person's own…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #16 · Compounds › Cagrilintide & amylin analogues · 24 Dec 2025 · 2 likes The honest summary of the evidence base: a coherent mechanism, good phase 2 data in combination, and much less standalone human data than the volume of discussion…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #2 · Practice › Administration · 20 Dec 2025 · 0 likes Leave real distance between consecutive sites rather than moving a centimetre. Repeatedly injecting one area changes the local tissue over time and eventually changes…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #37 · Pharmacology › Pharmacokinetics · 13 Dec 2025 · 7 likes My experience of Half-life contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.
-
Meeting a protein target on a suppressed appetite Replied, post #41 · Nutrition & Training › Protein & intake · 10 Dec 2025 · 27 likes Post #39 and I disagree about the size of the effect, not about the direction. Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #51 · Compounds › Tirzepatide · 7 Dec 2025 · 1 like Gastrointestinal effects were comparable in character to the GLP-1 monoagonists across the programme. Individual reports here vary in both directions, which is what you…
-
Prescription requirements and telehealth models Replied, post #50 · Sourcing › Regulatory · 6 Dec 2025 · 7 likes Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so. That is where I would start, not where I…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #63 · Practice › Interactions · 5 Dec 2025 · 12 likes The arithmetic in post #62 is right; the assumption feeding it is the part to check. Anticoagulants: no direct interaction with the compounds in this class. Weight loss…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #37 · Analytics › Impurities & related substances · 21 Nov 2025 · 14 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile… Replied, post #8 · Compounds › Semaglutide · 11 Nov 2025 · 4 likes Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
-
What a purity-only report leaves out Replied, post #48 · Sourcing › Independent verification · 15 Oct 2025 · 0 likes Answering the question post #46 raises rather than the one it answers. I keep a log for purity-only specifically because my memory of it turned out to be systematically…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #78 · Practice › Reconstitution · 14 Oct 2025 · 1 like Building on post #76 rather than restating it. I would put moderate confidence on the mainstream reading of decimal-point error and no more. That is not scepticism for…
-
New subcategory: rationale and scope Replied, post #15 · Meta › Announcements · 13 Oct 2025 · 27 likes Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if you want to stay current. The strength of my opinion…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #101 · Analytics › HPLC & UHPLC · 10 Oct 2025 · 0 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #109 · Evidence › Preprints · 4 Oct 2025 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Gauge and length selection for subcutaneous injection Replied, post #33 · Devices › Syringes & needles · 25 Sep 2025 · 17 likes Taking post #31 at face value and following it one step further. Nobody has said the unglamorous part of gauge and length selection yet, so: most of the variation is…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #26 · Data & Tools › Datasets · 7 Sep 2025 · 28 likes Post #23 answers the question as asked. The question underneath it is different. Nobody has said the unglamorous part of Aggregated purity results across four yet, so:…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #83 · Evidence › Journal club · 7 Sep 2025 · 0 likes Confirming post #80 from a second method, which matters more than confirming it from a second person. My position on orforglipron phase 2 is current rather than…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #68 · Evidence › Journal club · 2 Sep 2025 · 9 likes Post #64 and I disagree about the size of the effect, not about the direction. Checked the orforglipron phase 2 claim against the primary source this morning. It…
-
A ten-fold dose error caught before injection Replied, post #89 · Devices › Syringes & needles · 27 Aug 2025 · 0 likes That is consistent with mine, for whatever one more account is worth.
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #22 · Evidence › Journal club · 12 Aug 2025 · 2 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.
-
Travel coolers and how long they really hold Replied, post #72 · Devices › Cold chain · 7 Aug 2025 · 0 likes Narrowing post #69, because the general version has more than one answer. Something worth flagging about travel coolers: the strongest-sounding claims in this thread…
-
When a preprint is the best available evidence and we say so Replied, post #23 · Evidence › Preprints · 4 Aug 2025 · 0 likes Thank you for the correction. I would rather find out here than later.
-
How to research a compound with no human data without deceiving yourself Replied, post #10 · Compounds › Other compounds · 30 Jul 2025 · 31 likes On post #8 — agreed on the reasoning, with one qualification. On research a compound: the maintained page in the documentation commons covers the general case with…
-
[2026 update] Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA Started this topic · Compounds › Tirzepatide · 28 Jul 2025 · 25 likes Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA — setting out what I have, and where I think it stops being reliable. Reading back through what has been…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #40 · Analytics › Home & field testing · 19 Jul 2025 · 0 likes The right question for any home test is: what physical quantity does it measure, and what would have to be true for that quantity to answer your question? Most…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #13 · Analytics › Method validation · 16 Jul 2025 · 20 likes Post #11 put the caveat in the right place and I want to underline it. Practical note on Specificity: write down what you expect before you look. The number of times I…
-
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #5 · Start Here › Welcome · 21 Jun 2025 · 14 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Antibiotics and a course of something with delayed emptying Replied, post #67 · Practice › Interactions · 17 Jun 2025 · 21 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #61 · Access › Insurance & coverage · 11 Jun 2025 · 25 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
Pregnancy as an absolute contraindication Replied, post #57 · Safety › Contraindications · 19 May 2025 · 7 likes Labelling differs between jurisdictions for the same molecule, so quoting a contraindication should say which document it comes from. Somebody will have a better source…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #41 · Outcomes › Body composition · 14 May 2025 · 21 likes Post #38 answers the question as asked. The question underneath it is different. Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #55 · Data & Tools › Calculators · 7 May 2025 · 25 likes The number people quote for Validating a calculator against hand is a central estimate presented without its interval, and the interval is wide enough that the estimate…
-
Lean mass preservation: what the evidence supports Started this topic · Outcomes › Body composition · 1 May 2025 · 61 likes Lean mass preservation: what the evidence supports Writing it up because I had to work it out twice and would rather nobody else did. Trying to work out what would…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #83 · Evidence › Journal club · 21 Apr 2025 · 8 likes Worth stating the null on STEP 1 before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
-
Follow-up: What other technical communities get right that we do not Replied, post #71 · Lounge › Off topic · 18 Apr 2025 · 13 likes This is the sort of exchange that makes the archive worth searching.
-
Sequence verification for an obscure compound: how it is done Replied, post #7 · Compounds › Other compounds · 6 Apr 2025 · 15 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #52 · Compounds › Semaglutide · 25 Mar 2025 · 4 likes The arithmetic in post #51 is right; the assumption feeding it is the part to check. Adding the boring version of SELECT, because the interesting version keeps getting…
-
Validating a method you did not develop — does this still hold? Replied, post #144 · Analytics › Method validation · 21 Mar 2025 · 28 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #147 · Sourcing › Vendor reports · 19 Mar 2025 · 20 likes Post #146 is the version of this I will quote in future. One addition. Where you have no independent result, a documentation report is still worth filing: what the…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #33 · Sourcing › Vendor reports · 16 Mar 2025 · 0 likes Post #30 is right about the mechanism and I think understates the practical bit. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #5 · Devices › Syringes & needles · 10 Mar 2025 · 0 likes Answering the question post #3 raises rather than the one it answers. Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid,…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #97 · Data & Tools › Calculators · 19 Feb 2025 · 20 likes Building on post #96 rather than restating it. A saved calculation is worth more than a remembered one. Write down the inputs alongside the result, because the result…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #12 · Practice › Reconstitution · 12 Jan 2025 · 0 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #33 · Compounds › Oral incretins · 9 Jan 2025 · 0 likes This follows post #32 rather than contradicting it. SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH…
-
Isotonicity and what happens when you get it wrong Replied, post #21 · Pharmacology › Formulation chemistry · 8 Jan 2025 · 0 likes Adding the measurement that post #20 says would settle it. The version of isotonicity that circulates here is a simplification of a simplification. It is not wrong, but…
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #29 · Safety › Adverse events · 21 Dec 2024 · 3 likes The published trial rates come from supervised populations on defined schedules and are not comparable to rates derived from who chooses to post.
-
Building a sensible monitoring schedule with your prescriber Replied, post #49 · Clinical › Bloodwork · 20 Dec 2024 · 5 likes If someone has run building a sensible monitoring schedule properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has…
-
Coming back to: When to suspect the method rather than the sample Replied, post #100 · Analytics › Method validation · 19 Dec 2024 · 3 likes Post #96 put the caveat in the right place and I want to underline it. Robustness testing deliberately varies the parameters most likely to drift — organic percentage,…
-
What we do not know about retatrutide, listed explicitly Replied, post #18 · Compounds › Retatrutide · 11 Dec 2024 · 7 likes On post #14 — agreed on the reasoning, with one qualification. Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of…
-
[2026 update] New subcategory: rationale and scope Replied, post #30 · Meta › Announcements · 29 Nov 2024 · 18 likes Post #27 is the version of this I will quote in future. One addition. Last note on this: announcements here get more replies than most topics and almost all of them are…
-
Why our vendor pages link the storefront and mark it sponsored Replied, post #14 · Sourcing › Vendor reports · 21 Nov 2024 · 11 likes Post #13 is the version of this I will quote in future. One addition. What I want from this vendor pages link the storefront thread is the list of things that would…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #9 · Nutrition & Training › Protein & intake · 17 Nov 2024 · 29 likes Adding the measurement that post #6 says would settle it. The mechanism is not mysterious. Substantial energy restriction with inadequate protein and no resistance…
-
Time to steady state after a dose increase Replied, post #42 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 20 likes Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why the cytochrome interaction questions that dominate small-molecule…
-
Identical chromatograms across two different lots Replied, post #37 · Sourcing › Red flags · 15 Oct 2024 · 10 likes Post #36 is the version of this I will quote in future. One addition. What I would check first on identical chromatograms is whether the thing being measured moved or…
-
Blind submission and why it changes minds Replied, post #78 · Sourcing › Independent verification · 4 Oct 2024 · 8 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. Noting that I have skin in this question…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #35 · Evidence › Journal club · 5 Sep 2024 · 3 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #30 · Compounds › Semaglutide · 31 Aug 2024 · 3 likes Following this. I have the same question and no better information than the first post.
-
Assessing a warm arrival: the decision process — one year on Replied, post #128 · Sourcing › Logistics · 2 Jun 2024 · 0 likes Post #124 and I disagree about the size of the effect, not about the direction. Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is…